COMMUNIQUÉ DE PRESSE
News
-
-
COMMUNIQUÉ DE PRESSE
PHAXIAM Therapeutics presents an ambitious development strategy to take advantage of the rapidly evolving Phages therapy area
PHAXIAM Therapeutics presents an ambitious development strategy to take advantage of the rapidly evolving Phages therapy area. Webinar discussing PTMP and IPT models with revenue projections and positive outlook for achieving profitability by 2027 -
COMMUNIQUÉ DE PRESSE
Original-Research: Almonty Industries Inc. (von Sphene Capital GmbH): Buy
Sphene Capital GmbH upgrades Almonty Industries Inc.'s target price to CAD 3.21 from CAD 2.31, expecting a share price increase of 260.7%. They maintain a Buy rating based on Almonty's strong financial performance -
-
-
-
-
COMMUNIQUÉ DE PRESSE
Jericho Energy Ventures' Hydrogen Technologies Granted UK Patent as it Continues to Advance its Zero-Emission Combustion Technology
Jericho Energy Ventures Inc. announces UK patent for zero-emission hydrogen-oxygen combustion technology, continuing IP protection strategy to transform hydrogen energy market -
-
COMMUNIQUÉ DE PRESSE
EQS-Adhoc: Knaus Tabbert AG: Investitgations of the business premises of Knaus Tabbert AG by order of the Landshut public prosecutor's office
Knaus Tabbert AG's business premises investigated by the Landshut public prosecutor's office following allegations against individual company members. Company not directly implicated
